NASDAQ : AIMD
$0.01 (0.71%)
%
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
-
-
change: 0.0 | last:
-
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-04-17 | Ting Chuan Lee | 935.71K | 10.98% |
| 2026-04-17 | AINOS INC | 491.26K | 5.76% |
| 2026-04-17 | Chun-Jung Tsai | 687K | 8.06% |
| 2026-04-15 | ASE Test, Inc. | 667.08K | 8.40% |
| 2026-04-15 | ASE Technology Holding Co., Ltd. | 667.08K | 8.40% |
| 2026-01-30 | AINOS INC | 491.26K | 6.76% |
| 2026-01-30 | Taiwan Carbon Nano Technology Corporation | 989.92K | 13.62% |
| 2026-01-27 | ScentAI Inc. | 1.16M | 16.50% |
| 2025-11-28 | Ting Chuan Lee | 365.71K | 6.00% |
| 2025-11-28 | Chun-Jung Tsai | 357K | 6.00% |
| 2025-11-28 | AINOS INC | 491.26K | 8.52% |
| 2025-11-28 | Chun-Hsien Tsai | 410.37K | 7.00% |
| 2025-10-09 | Taiwan Carbon Nano Technology Corporation | 1.04M | 21.79% |
| 2025-10-09 | Ainos Inc. | 491.26K | 9.13% |
| 2025-04-11 | Chun-Hsien Tsai | 1.65M | 8.31% |
| 2025-04-11 | Ting Chuan Lee | 1.43M | 7.20% |
| 2025-04-09 | Ainos Inc. | 2.46M | 10.68% |
| 2025-03-12 | ASE Technology Holding Co., Ltd. | 3.15M | 17.00% |
| 2025-03-12 | ASE Test, Inc. ("ASE Test Taiwan") | 3.15M | 17.00% |
| 2025-03-12 | Ainos, Inc. | 2.46M | 12.10% |
| 2024-08-21 | Carbon Nano Technology Corporation (“TNCT”) | 5.5M | 40.23% |
| 2024-05-08 | ASE Test, Inc. (“ASE Test Taiwan”) | 2.31M | 27.40% |
| 2024-05-08 | (“ASX”) | 2.31M | 27.40% |
| 2015-10-13 | Stephen T. Chen, PhD | 2.7M | 13.39% |
| 2009-10-21 | CYTO BIOTECH, INC. | 3M | 6.70% |
| 1996-09-06 | Hayashibara Biochemical Laboratories, Inc. | 1.23M | 24.10% |
| 1996-09-06 | Hayashibara Biochemical Laboratories, Inc. | 1.23M | 24.10% |
| 1996-09-06 | Joseph M. Cummins | 696.8K | 13.60% |
| 1996-09-06 | Joseph M. Cummins | 696.8K | 13.60% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.64 | 4.27M | $7M | $417.35K | $11M | $17.59M |
| 2024-12-31 | $2.28 | 9.5M | $21.67M | $3.89M | $12M | $29.78M |
| 2023-12-31 | $10.25 | 4.1M | $42.01M | $1.89M | $5.96M | $46.08M |
| 2022-12-31 | $15.50 | 2.73M | $42.28M | $1.85M | $1.27M | $41.69M |
| 2021-12-31 | $315.02 | 1.51M | $475.77M | $1.75M | $3.62M | $477.63M |
| 2020-12-31 | $57.40 | 543.08K | $31.17M | $22245 | $953K | $32.1M |
| 2019-12-31 | $57.40 | 2.15M | $123.23M | $409.04K | $444.58K | $123.26M |
| 2018-12-31 | $57.40 | 2.38M | $136.4M | $1.28M | $513.36K | $135.63M |
| 2017-12-31 | $57.40 | 1.51M | $86.73M | $1.98M | $886.48K | $85.63M |
| 2016-12-31 | $57.40 | 1.34M | $77.09M | $134.12K | $791.48K | $77.74M |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.94 | 7.36M | $14.27M | $1.42M | $11M | $23.85M |
| 2026-03-31 | $1.39 | 6.03M | $8.38M | $2.84M | $13.81M | $19.36M |
| 2025-12-31 | $1.64 | 6.03M | $9.89M | $417.35K | $11M | $20.47M |
| 2025-09-30 | $3.47 | 6.03M | $20.93M | $1.13M | $11M | $30.8M |
| 2025-06-30 | $2.83 | 6.03M | $17.07M | $1.22M | $11M | $26.85M |
| 2025-03-31 | $2.46 | 6.03M | $14.84M | $2.63M | $12M | $24.21M |
| 2024-12-31 | $2.28 | 9.5M | $21.67M | $3.89M | $12M | $29.78M |
| 2024-09-30 | $2.39 | 11.28M | $26.96M | $5.16M | $12.27M | $34.07M |
| 2024-06-30 | $4.03 | 6.52M | $26.27M | $8.01M | $13.9M | $32.16M |
| 2024-03-31 | $5.70 | 5.77M | $32.9M | $1.03M | $5.68M | $37.55M |
| 2023-12-31 | $10.25 | 4.31M | $44.2M | $1.89M | $5.96M | $48.27M |
| 2023-09-30 | $15.50 | 4.06M | $62.91M | $2.37M | $5.31M | $65.85M |